Your premium access has ended, but the best of Nation.Africa is still within reach. Renew now to unlock exclusive stories and ...

The Access and Allocation Mechanism (AAM) for mpox, a mechanism formed to counter mpox, has allocated an initial 899,000 ...

An initial 899,000 vaccine doses have been allocated to Nigeria and 8 other countries across Africa that have been hit ...

Bavarian Nordic’s mpox vaccine, Jynneos (MVA-BN), is set to be trialled in pregnant and breastfeeding women and infants. The Phase III trial (PregInPoxVac) will enrol around 350 pregnant women and 250 ...

“The supply includes contributions from multiple nations and organisations, including 1.85 million doses of MVA-BN from the ...

A total of 265,000 doses of the MVA-BN mpox vaccine arrived in Kinshasa in September. DRC expects to receive the LC-16 mpox vaccine, which has the potential to protect children. The mpox vaccination ...

The WHO has declared a global health emergency over a new strain of mpox rapidly spreading in Africa. Here’s what you need to ...

How worried should the UK public be about the new case of mpox identified in the UK? Health Correspondent Rebecca Thomas ...

The registrational trial is expected to support the Bavarian’s mpox/smallpox vaccine use in children between 2 and 11 years ...

Results from this study could support an extension of the current approval of MVA-BN to include children from 2 years of age ...

Credit: Getty Images Researchers examined the safety and immunogenicity of 2 doses of MVA-BN vaccine administered subcutaneously 28 days apart in adolescents aged 12 to 17 years compared to adults.

HealthDay News — The Modified Vaccinia Ankara-Bavarian Nordic (MVA-BN) vaccine, licensed in the United States to prevent smallpox and mpox, is well tolerated and seems effective in adolescents, ...